Cutaneous T-Cell Lymphoma, Unspecified
2 clinical trials · Condition
◉ Watch Cutaneous T-Cell Lymphoma, Unspecified
| Record | Firm | Date |
|---|---|---|
| Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma (NCT04234048) | SciTech Development, Inc. | 2023-12-18 |
| Modification of Extracorporeal Photopheresis in Cutaneous T-cell Lymphoma or Chronic Graft-versus-host Disease (NCT03109353) | St. Olavs Hospital | 2017-09-20 |
Track Cutaneous T-Cell Lymphoma, Unspecified automatically
Every clearance here is in the API, with alerts when new ones post.